March 12, 2018 / 8:54 PM / 5 months ago

BRIEF-Kura Oncology Inc - Co Entered Into An Amended And Restated Sales Agreement With Cowen And Company​

March 12 (Reuters) - Kura Oncology Inc:

* KURA ONCOLOGY INC - ‍ON MARCH 12, 2018, CO ENTERED INTO AN AMENDED AND RESTATED SALES AGREEMENT WITH COWEN AND COMPANY, LLC - SEC FILING​

* KURA ONCOLOGY-INCREASED MAXIMUM AGGREGATE OFFERING PRICE OF SHARES OF CO'S COMMON STOCK, THAT IS CO MAY OFFER AND SELL FROM $100.0 MILLION TO $160.0 MILLION​ Source text (bit.ly/2HrCHZZ) Further company coverage: (Reuters.Brief@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below